ArticleBMC infectious diseases2025
The effect of latent Mycobacterium tuberculosis infection on ovarian reserve and pregnancy outcomes among infertile women in China.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of three-month tuberculosis preventive treatment (3HP) on IVF-ET outcomes in infertile women with tuberculosis infection: a retrospective before-after study.BMC pregnancy and childbirth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLatent Mycobacterium tuberculosis infection (LTBI) is common among patients with infertility, yet its effects on ovarian reserve function and pregnancy outcomes in women undergoing assisted reproductive technology (ART) remain unclear. This study aimed to investigate the impact of LTBI on ovarian reserve and clinical pregnancy outcomes in infertile women treated with ART.
methodsA total of 429 infertile female patients undergoing ART were enrolled in this study. Based on QuantiFERON-TB Gold Plus (QFT-Plus) results, patients were divided into LTBI and non-LTBI groups. Ovarian reserve markers and pregnancy outcomes were compared between the two groups.
resultsWomen in the LTBI group exhibited significantly lower anti-Müllerian hormone (AMH) levels than those in the non-LTBI group (3.42 ± 2.20 vs. 4.53 ± 3.30, p < 0.05). Although the LTBI group showed a lower clinical pregnancy rate (57.14% vs. 68.58%, p = 0.075), as well as reduced biochemical pregnancy rates (69.84% vs. 75.41%) and an increased rate of ectopic pregnancy (5.26% vs. 1.19%), these differences did not reach statistical significance (p > 0.05).
conclusionsThe findings indicate that LTBI in women undergoing ART is associated with a significantly diminished ovarian reserve, as evidenced by lower AMH levels, and may potentially lead to adverse pregnancy outcomes, although these outcomes did not differ significantly between the groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.